Suppr超能文献

骨髓基质细胞产生的旁分泌因子诱导前列腺癌细胞凋亡和神经内分泌分化。

Paracrine factors produced by bone marrow stromal cells induce apoptosis and neuroendocrine differentiation in prostate cancer cells.

机构信息

Department of Biological Sciences and Center for Translational Cancer Research, University of Delaware, Newark, Delaware, USA.

出版信息

Prostate. 2011 Feb 1;71(2):157-67. doi: 10.1002/pros.21231.

Abstract

BACKGROUND

Preferential bony metastasis of human prostate cancer (PCa) cells contributes to disease mortality and morbidity. Local factors in bone stromal extracellular matrix microenvironment affect tumor growth through paracrine interactions between tumor and stromal cells.

METHODS

Using co-culture and medium transfer, we used several methods to assess interactions between PCa and bone stromal cells using three PCa cell lines: PC3, LNCaP, and the LNCaP derivative, C4-2B.

RESULTS

Co-culture of LNCaP and C4-2B cells with bone marrow stromal cell lines, HS27a and HS5, decreased cell number, as did culture with conditioned medium (CM) harvested from these two cell lines suggesting a soluble paracrine factor was responsible. PC3 cell growth was unaffected. CM harvested from bone stromal cell lines triggered apoptosis in LNCaP and C4-2B cell lines, but not in PC3 cells. Surviving C4-2B cells grown in bone stromal cell CM over several days were growth arrested, suggesting presence of a growth inhibitor. Apoptosis induced by CM was dose-dependent. Flow cytometry demonstrated that over a 5-day culture period in stromal cell CM, LNCaP, and C4-2B cell lines, but not PC3 cells, underwent greater apoptosis than parallel cultures in SF medium. The LNCaP and C4-2B cells showed morphology and biomarker expression consistent with transdifferentiation towards a neuroendocrine phenotype after exposure to stromal cell CM.

CONCLUSIONS

The reactive bone stromal microenvironment initially is hostile to PCa cells producing widespread apoptosis. Activation of transdifferentiation in a subset of apoptotic resistant cells may support phenotypic adaptation during disease progression in bone, eventually favoring lethal disease.

摘要

背景

人类前列腺癌(PCa)细胞优先发生骨转移,导致疾病死亡率和发病率上升。骨基质细胞外基质微环境中的局部因素通过肿瘤细胞与基质细胞之间的旁分泌相互作用影响肿瘤生长。

方法

我们使用三种 PCa 细胞系(PC3、LNCaP 和 LNCaP 衍生的 C4-2B)通过共培养和培养基转移,使用几种方法评估 PCa 与骨基质细胞之间的相互作用。

结果

LNCaP 和 C4-2B 细胞与骨髓基质细胞系 HS27a 和 HS5 共培养以及培养这些两种细胞系收获的条件培养基(CM)均导致细胞数量减少,这表明可溶性旁分泌因子是起作用的。PC3 细胞的生长不受影响。从骨基质细胞系收获的 CM 可触发 LNCaP 和 C4-2B 细胞系发生细胞凋亡,但对 PC3 细胞没有作用。在骨基质细胞 CM 中生长数天的存活 C4-2B 细胞被生长抑制,这表明存在生长抑制剂。CM 诱导的凋亡呈剂量依赖性。流式细胞术显示,在基质细胞 CM 中培养 5 天期间,LNCaP 和 C4-2B 细胞系而非 PC3 细胞系经历了比平行培养于 SF 培养基中更多的细胞凋亡。LNCaP 和 C4-2B 细胞在暴露于基质细胞 CM 后表现出形态和生物标志物表达,与向神经内分泌表型的转分化一致。

结论

最初,反应性骨基质微环境对 PCa 细胞具有敌意,导致广泛的细胞凋亡。在凋亡抵抗细胞亚群中激活转分化可能支持疾病进展过程中在骨中的表型适应,最终有利于致命性疾病。

相似文献

4
Regulation of prostate cancer cell migration toward bone marrow stromal cell-conditioned medium by Wnt5a signaling.
Mol Med Rep. 2013 Nov;8(5):1486-92. doi: 10.3892/mmr.2013.1698. Epub 2013 Sep 23.
5
Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis.
J Bone Miner Res. 2004 Oct;19(10):1712-21. doi: 10.1359/JBMR.040703. Epub 2004 Jul 7.
6
p62/SQSTM1 is required for cell survival of apoptosis-resistant bone metastatic prostate cancer cell lines.
Prostate. 2014 Feb;74(2):149-63. doi: 10.1002/pros.22737. Epub 2013 Sep 30.
7
Expression of two WFDC1/ps20 isoforms in prostate stromal cells induces paracrine apoptosis through regulation of PTGS2/COX-2.
Br J Cancer. 2016 May 24;114(11):1235-42. doi: 10.1038/bjc.2016.91. Epub 2016 Apr 26.
8
Prostate carcinoma cells that have resided in bone have an upregulated IGF-I axis.
Prostate. 2004 Jan 1;58(1):41-9. doi: 10.1002/pros.10299.

引用本文的文献

2
Berbamine Inhibits Cell Proliferation and Migration and Induces Cell Death of Lung Cancer Cells via Regulating c-Maf, PI3K/Akt, and MDM2-P53 Pathways.
Evid Based Complement Alternat Med. 2021 Jul 8;2021:5517143. doi: 10.1155/2021/5517143. eCollection 2021.
3
Chronic IL-1 exposure drives LNCaP cells to evolve androgen and AR independence.
PLoS One. 2020 Dec 16;15(12):e0242970. doi: 10.1371/journal.pone.0242970. eCollection 2020.
4
Potent Activity of an Anti-ICAM1 Antibody-Drug Conjugate against Multiple Myeloma.
Clin Cancer Res. 2020 Nov 15;26(22):6028-6038. doi: 10.1158/1078-0432.CCR-20-0400. Epub 2020 Sep 11.
5
Proteoglycans in the Pathogenesis of Hormone-Dependent Cancers: Mediators and Effectors.
Cancers (Basel). 2020 Aug 24;12(9):2401. doi: 10.3390/cancers12092401.
9
SDF-1 induces TNF-mediated apoptosis in cardiac myocytes.
Apoptosis. 2018 Jan;23(1):79-91. doi: 10.1007/s10495-017-1438-3.

本文引用的文献

1
Cancer statistics, 2009.
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.
2
Osteosclerotic prostate cancer metastasis to murine bone are enhanced with increased bone formation.
Clin Exp Metastasis. 2009;26(7):641-51. doi: 10.1007/s10585-009-9263-x. Epub 2009 May 7.
3
Effect of bisphosphonates on pain and quality of life in patients with bone metastases.
Nat Clin Pract Oncol. 2009 Mar;6(3):163-74. doi: 10.1038/ncponc1323. Epub 2009 Feb 3.
4
Cancer-related axonogenesis and neurogenesis in prostate cancer.
Clin Cancer Res. 2008 Dec 1;14(23):7593-603. doi: 10.1158/1078-0432.CCR-08-1164.
7
Osteotropic cancers: from primary tumor to bone.
Cancer Lett. 2009 Jan 18;273(2):177-93. doi: 10.1016/j.canlet.2008.05.044. Epub 2008 Jul 15.
8
Osteoclast targeted therapy for prostate cancer: bisphosphonates and beyond.
Urol Oncol. 2008 Jul-Aug;26(4):420-5. doi: 10.1016/j.urolonc.2007.11.004.
9
Correlation between BMD and bone scintigraphy in patients with prostate cancer.
Urol Oncol. 2008 May-Jun;26(3):250-3. doi: 10.1016/j.urolonc.2007.05.027. Epub 2007 Dec 3.
10
The bone microenvironment in metastasis; what is special about bone?
Cancer Metastasis Rev. 2008 Mar;27(1):41-55. doi: 10.1007/s10555-007-9109-4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验